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Upstream regulatory factor (USF) and sterol regulatory element binding protein (SREBP) play key roles in
the transcriptional regulation of the fatty acid synthase (FAS) gene by feeding and insulin. Due to the dual
binding specificity of SREBP, as well as the presence of multiple consensus sites for these transcription factors
in the FAS promoter, their physiologically relevant functional binding sites have been controversial. Here, in
order to determine the occupancy of the putative USF and SREBP binding sites, we examined their protein-
DNA interactions in living animals by using formaldehyde cross-linking and immunoprecipitation of chroma-
tin and tested the function of these elements by employing mice transgenic for a reporter gene driven by various
5 deletions as well as site-specific mutations of the FAS promoter. We show that the 332 and 65 E-boxes
are bound by USF in both fasted and refed mice, while the 150 SRE is bound by SREBP-1 only in refed mice.
We also found that mutation of either the150 SRE or the65 E-box abolishes the feeding-induced activation
of the FAS promoter in transgenic mice. Furthermore, in vivo occupancy of the FAS promoter by SREBP in the
fed state can be prevented by mutation not only of the 150 SRE but, unexpectedly, of the 65 E-box as well.
We conclude that the FAS promoter is activated during refeeding via the induced binding of SREBP to the
150 SRE and that USF binding to the 65 E-box is also required for SREBP binding and activation of the
FAS promoter.
Fatty acid synthase (FAS), a central enzyme in de novo
lipogenesis in mammals, catalyzes all the reactions for the
conversion of acetyl-coenzyme A (CoA) and malonyl-CoA to
palmitate. FAS gene transcription is under tight nutritional
and hormonal control in lipogenic tissues, namely liver and
adipose tissue (13, 20, 46). FAS transcription is not detectable
in the lipogenic tissues of fasted mice, whereas feeding a high-
carbohydrate, fat-free diet increases FAS transcription dra-
matically (30, 31). Increased circulating insulin and decreased
glucagon levels participate in the induction of FAS expression
(31). Knockout or transgenic mice overexpressing sterol regu-
latory element-binding protein (SREBP) and upstream stimu-
latory factor (USF) demonstrated that these transcription fac-
tors play key roles in the regulation of FAS transcription (6, 14,
18, 21, 27, 41, 42, 47, 48). USF belongs to the basic helix-loop-
helix (bHLH) leucine zipper family of transcription factors,
and it binds as a heterodimer to the palindromic motif
CANNTG, known as an E-box, in the promoters regulated by
this transcription factor. SREBP also belongs to the bHLH
transcription factor family and, in general, regulates transcrip-
tion through binding to sterol regulatory elements (SREs),
5-ATCACCCCAC-3, located in the promoters of its target
genes (9, 11, 12, 23, 50). However, due to an atypical tyrosine
residue present in its conserved basic DNA-binding domain,
SREBP can also bind to E-box, at least in vitro (19). There are
three SREBP isoforms, SREBP-1a, SREBP-1c, and SREBP-2.
SREBPs activate various genes involved in cholesterol and
fatty acid biosynthesis. However, only SREBP-1c expression is
induced by feeding and insulin, and its role is restricted to
regulation of fatty acid and fat synthesis (15).
Using 3T3-L1 adipocytes, we originally reported that the
65 E-box mediates insulin activation of the FAS gene and
that USF1 and USF2 bind to the E-box (47, 48). However, by
generating mice transgenic for various 5-deletion FAS pro-
moter-chloramphenicol acetyltransferase (CAT) constructs,
we found that the 131 FAS promoter construct, containing
the 65 E-box, is not sufficient for the feeding and insulin-
mediated activation of the FAS promoter in vivo. Neverthe-
less, a region from278 to131, containing the150 SRE, as
well as a more upstream region from444 to278, containing
an additional E-box at 332, are required for high-level acti-
vation of the FAS promoter by feeding and insulin (27). Others
have reported that sterol regulation of FAS transcription in
HepG2 cells occurs via binding of SREBP to two tandem
copies of SREs overlapping the 65 E-box (3, 25). Nutrient
and insulin-mediated FAS promoter activation has also been
attributed to SREBP binding to the 65 E-box due to the dual
binding specificity of SREBP mentioned above (10, 18). In our
hands, however, specific mutations around the E-box that dras-
tically reduce binding of SREBP but not USF to this region in
vitro do not affect insulin regulation of the FAS promoter in
3T3-L1 adipocytes (47). In any case, as we reported previously,
the first 131 bp of the FAS promoter, containing the 65
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sequence, are unable to confer nutritional and insulin regula-
tion of the CAT reporter gene in transgenic mice (27).
Although much knowledge has been gained during the past
few years on transcriptional regulation of the FAS gene by
nutritional and hormonal stimuli, there are important ques-
tions yet to be answered, including the physiologically relevant
binding sites for SREBP and USF and the roles they play in
vivo. Here, we generated and used for chromatin formalde-
hyde cross-linking and immunoprecipitation mice transgenic
for the CAT gene driven by various 5 deletions of FAS pro-
moter with site-specific mutations in order to determine the
occupancy and functional significance of the 150 SRE and
the 65 E-box in living animals. We report herein that, in vivo,
SREBP is bound only to the 150 SRE and not to the 65
region where both USF and SREBP can bind in vitro. Fur-
thermore, SREBP is bound to the 150 SRE only during
refeeding. We also unequivocally establish that both the 150
SRE and 65 E-box are required for nutritional activation of
the FAS promoter in vivo. Surprisingly, upon prevention of
USF binding to the 65 E-Box by mutation, SREBP-1 does
not bind to the 150 SRE in refed transgenic mice, suggesting
a functional interaction between these two proteins in tran-
scriptional activation of FAS.
MATERIALS AND METHODS
Plasmid construction and production of transgenic mice. Transgenic mice
harboring the CAT gene driven by various 5 deletions of the FAS promoter
were generated, and the transgenic mice were identified by PCR of tail DNA as
described previously (27, 45). The reporter gene construct for the 444(65m)
FAS-CAT transgenic line was generated by mutating the 65/60 sequence to
5-GAATTC-3 by site-directed mutagenesis of the 2100-FAS-CAT plasmid
previously described (45). The 444(150m) FAS-CAT construct originated in
a similar manner by mutation of the 150/141 SRE sequence to 5-ATCGA
TCCAC-3 by site-directed mutagenesis of the 2100-FAS-CAT plasmid. The
mutated plasmids were digested with DraIII and KpnI to release the desired
constructs, which were gel purified and injected into pronuclei of fertilized
mouse embryos. Hemizygous transgenic progenies (F1) were obtained and iden-
tified as previously described (27). Multiple independent founder lines for the
different FAS promoter constructs were used as described previously, and es-
sentially the same results were obtained. Double-transgenic mice for the FAS-
CAT constructs and the PEPCK-SREBP-1a transgene were generated as previ-
ously described (21).
Animal treatment. The animals had access ad libitum to food pellets contain-
ing 58% carbohydrate. Mice either were fasted for 24 h or were fasted for 24 h
and then refed a high-carbohydrate (70%), fat-free diet for 16 h. In the exper-
iments where animals carrying both the FAS-CAT and the PEPCK-SREBP-1a
transgenes were used, the mice were fed a synthetic low-carbohydrate protein
diet (no. 5789C; Purina Mills Inc.) containing 71% (wt/wt) casein and 4.25
(wt/wt) sucrose for 2 weeks prior to the fasting-refeeding experiments (40).
RNA isolation and RNase protection assay. Dissected livers were immediately
snap-frozen in liquid nitrogen. Total RNA was isolated from the frozen tissues
using TRIzol reagent (Invitrogen). RNAs were reprecipitated in 0.5 M ammo-
nium acetate and resuspended in RNase-free water containing 0.5% sodium
dodecyl sulfate. RNase protection assays were carried out as described previously
(27) using 10 g of total RNA and the MaxiScript/RPA-III kit (Ambion).
Protected fragments were separated by denaturing polyacrylamide gel electro-
phoresis, and the dried gel was exposed to X-ray film for 12 to 30 h.
Formaldehyde cross-linking and immunoprecipitation of chromatin. Chroma-
tin immunoprecipitation (ChIP) was performed according to the previously de-
scribed procedure with minor modifications (34). The livers from different trans-
genic mice were minced and formaldehyde cross-linked for 10 min by adding
formaldehyde directly to the tissues in phosphate-buffered saline to a final con-
centration of 1% at room temperature. Cross-linking was stopped by the addition
of glycine to a final concentration of 0.125 M. Cross-linked liver samples were
dounced on ice with a B douncer six times to disaggregate the hepatocytes,
washed twice with cold 1 phosphate-buffered saline, and swelled in RSB buffer
(3 mM MgCl2, 10 mM NaCl, 10 mM Tris-chloride [pH 7.4], in the presence of
0.1% NP-40 and protease inhibitors [0.5 mM phenylmethylsulfonyl fluoride, 100
ng of leupeptin per ml, 100 ng of aprotinin per ml]). Liver samples were dounced
again on ice 10 additional times to aid nuclei release. Nuclei were pelleted by
centrifugation and resuspended in nuclei lysis buffer (1% sodium dodecyl sulfate,
10 mM EDTA, 50 mM Tris-chloride [pH 8.1] plus the protease inhibitors). The
resulting chromatin solution was sonicated for 15 10-s pulses at maximum power.
We obtained four primary aliquots from each cross-linked liver. After centrifu-
gation, the supernatant of one aliquot was precleared with blocked protein
A-positive Staph cells (Roche), diluted 1:3 with dilution buffer (0.01% sodium
dodecyl sulfate, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-chloride [pH
8.1], 167 mM NaCl, and the protease inhibitors) and divided into aliquots. Four
micrograms of anti-USF1 antibody (sc-229 X; Santa Cruz), 30 g of anti-
SREBP-1 (sc-8984 X; Santa Cruz) antibody that recognizes both 1a and 1c forms,
or 5 l of a nonrelated antibody (anti-pref-1 serum; Covance) were added to
each aliquot of chromatin and incubated on an oscillating platform for 16 h at
4°C. Another aliquot was incubated with no antibody. When anti-acetylated H3
and H4, anti-NF-Y, anti-Sp1, or anti-Sp3 antibodies were used, 5 l for anti-
acetylated H3 (06-599; Upstate), 5 l for anti-acetylated H4 (#06-866; Upstate),
30 g of anti-NF-Y (sc-10779 X; Santa Cruz), 30 g of anti-Sp1 (07-124; Up-
state), and 4 g of anti-Sp3 (sc-644 X; Santa Cruz) antibody were added.
Antibody-protein-DNA complexes were isolated by immunoprecipitation with
preblocked protein A-positive Staph A cells, and after extensive washing, these
complexes were eluted. Following addition of NaCl to a final concentration of 0.3
M and 1 l of RNase A (10 mg/ml), samples were incubated in a 67°C water bath
to reverse the formaldehyde cross-links. After digestion with proteinase K, sam-
ples were extracted with phenol-chloroform–isoamyl alcohol and chloroform-
isoamyl alcohol. DNA was precipitated and resuspended in water. Samples were
analyzed by PCR using 1/10 of the sample and suitable primers (endogenous
FAS, 5-CAGCCCCGACGCTCATTGG-3 and 5-GCCCGCCTATCCTTCCA
CTG-3; FAS-CAT, 5-CAGCCCCGACGCTCATTGG-3 and 5-GCTTCCTT
AGCTCCTGAAAATCTCGCC-3; LDLR, 5-GCTTCTGGGGTTAAAAGAG
AC-3 and 5-CCCGCTGCAAACACTGGATCG-3; Exon 32, 5-ATCCTG
CTGGACGCCCTTTTTG-3 and 5-TTGCCAATGTGTTTCCCCTGAGCC-3;
CAD, 5-TGACTAGCGGTACCGGGGTTGCTGCTGTGGAACC-3 and 5-CG
GGCTTGCTTACCCACCTTCCCCAGCAGTCGACAC-3). As a control for the
initial amount of DNA present in each sample, the supernatant of the “no antibody”
sample was collected, labeled “input,” and processed simultaneously with the rest of
the samples, starting at the point where the cross-links were reversed. The input
sample was diluted 1:100 prior to the PCR. PCR products were separated by
electrophoresis on a 2% agarose gel and visualized by ethidium bromide staining.
RESULTS
FAS is transcriptionally regulated by nutritional and hor-
monal stimuli, including stimulation by fasting-refeeding and
insulin, and suppression by polyunsaturated fat feeding (26, 30,
31). Two transcription factors, USF and SREBP, have been
identified as key players in FAS regulation, both in vitro and in
vivo (6, 10, 18, 21, 27, 41, 47).
The goal of our present study was to examine the occupancy
of the FAS promoter by USF and SREBP in vivo and to
examine changes in the binding of these factors and their
function in fasted-refed conditions. We performed ChIP of
formaldehyde-cross-linked liver samples on fasted mice or on
fed mice that had been previously fasted. Before analyzing the
immunoprecipitated samples, we first performed PCR with a
serial dilution of the input chromatin. As shown in Fig. 1A,
dilutions of the sample resulted in a respective reduction in the
amount of PCR product generated, indicating that the signal
obtained is proportional to the amount of input DNA. For
subsequent experiments, we used input samples diluted 100-
fold. Next, we analyzed samples that were immunoprecipitated
with USF-1 or SREBP-1 antibodies. Since carbamoylphos-
phate synthetase-asparate carbamolytrasferase-dihydroorotase
(CAD) promoter has been shown by ChIP assay to be bound
by USF (5), we tested this promoter as a positive control for
our experiments. We could detect binding of USF to the CAD












promoter, whereas the “no antibody” or SREBP antibody im-
munoprecipitations did not produce any signal (Fig. 1B). Im-
munoprecipitation with an unrelated antibody did not produce
any signal either (Fig. 1C). We did not have a good candidate
promoter that can be used as a positive control for SREBP,
since binding of endogenous SREBP to any SREBP-regulated
gene has never been shown by ChIP or even by in vitro elec-
tromobility shift assays. We first examined the occupancy of
the FAS promoter by USF and SREBP (Fig. 1B). Binding of
USF to the proximal region of the FAS promoter could be
detected in both the fasted and refed states. On the other
hand, binding of SREBP could be detected not in fasted but
only in the refed state. As a negative control, we used primers
complementary to a downstream region of the FAS gene in
exon 32. There are no known USF or SREBP sites in this
region, and approximately 12 kbp of genomic DNA separate
exon 32 and the FAS promoter. As expected, no signal for this
downstream region of the FAS gene was detected in either the
USF or SREBP immunoprecipitates. This indicates that sig-
nals obtained in the PCRs corresponding to the proximal pro-
moter region of the FAS gene resulted from sequence-specific
interactions of these transcription factors with the DNA.
We next used the previously characterized 444 FAS-CAT
transgenic mice. We previously showed that the 444 FAS
promoter confers full transcriptional activation during feeding
and therefore contains all the elements necessary to mediate
induction of the FAS gene during fasting and refeeding (27).
We carried out ChIP assays on liver samples from these trans-
genic mice, and occupancy of the endogenous FAS promoter
and transgene promoter by USF and SREBP is shown in Fig.
1C. Similar to the results obtained in Fig. 1B for the endoge-
nous FAS promoter, binding of USF1 was detected in both the
fasted and refed states, whereas SREBP-1 binding was de-
tected in the refed state only. Identical results were observed
when we examined the occupancy of the 444 bp transgene
FAS promoter construct by USF-1 and SREBP-1 (Fig. 1C)
using transgene specific primers. While SREBP was not bound
to the transgene FAS promoter during the fasted state, its
binding to the transgene promoter was clearly detected after
refeeding. As in the case of the endogenous FAS promoter,
USF binding to the 444 FAS transgene promoter was de-
tected in both the fasted and refed states, without changes
during nutritional manipulations. The presence of two putative
USF binding sites (65 and 332 E-boxes) in this 444 FAS
promoter fragment did not allow us in this experiment to
distinguish whether USF was bound to either one or both of
the E-boxes. Overall, the binding pattern of these transcription
factors on the endogenous FAS promoter was indistinguish-
able from that of the transgene FAS promoter, further sup-
porting our working hypothesis that this promoter fragment
contains all the elements necessary and sufficient for transcrip-
tional stimulation of the FAS gene by USF and SREBP. To our
knowledge, this is the first time that binding of endogenous
SREBP to any promoter has been demonstrated in vivo. The
present results on the occupancy of the FAS promoter by
SREBP in vivo support our previous reports on the involve-
ment of this factor in FAS regulation during fasting and
refeeding (14, 18, 21). These results also support the functional
role we previously demonstrated for the 444 promoter frag-
ment, to contain all the sequences required for SREBP to
FIG. 1. In vivo binding of USF and SREBP to the FAS promoter
during fasting and refeeding. (A) Sonicated cross-linked-chromatin
samples from livers of mice that were fasted or refed were diluted 1:2,
1:10, 1:100, and 1:500. The diluted samples were subjected to PCR
amplification using specific primers complementary to the FAS-CAT
transgene. The PCR product was 230 bp in length. Results are repre-
sentative of those from input chromatin samples recovered from four
independent immunoprecipitation experiments. (B) The sonicated
cross-linked-chromatin samples from fasted and refed mice were im-
munoprecipitated with 4 g of antibody against USF and 30 g of
antibody against SREBP. Precipitation carried out without antibody
(No Ab) was used as a negative control. As an additional control, the
supernatant from the “no antibody” sample, representing the total
input chromatin (Input), was collected, processed as the immunopre-
cipitates, and included in the PCR. The immunoprecipitates were
analyzed by simultaneous PCRs using primers complementary to the
endogenous FAS-proximal promoter region and to a region within
exon 32 of the FAS gene. The sizes of the PCR products are indicated.
Sequences from the proximal CAD promoter were amplified from
fasted or refed mice in a separate experiment, and the size of the PCR
product is 350 bp. (C) Cross-linked chromatin samples from 444
FAS-CAT mice fasted or refed were immunoprecipitated with anti-
USF and anti-SREBP antibodies, and the DNA was analyzed by PCR
using the appropriate primers as described for panel B. The sizes of the
PCR generated fragments were 269 bp for endogenous FAS, 230 bp
for FAS-CAT, and 242 bp for LDL receptor (LDLR). Controls include
a precipitation lacking antibody (no Ab), lacking chromatin (mock),
and immunoprecipitation with an unrelated antibody (unrelated).












mediate FAS regulation (21). We also detected occupancy of
the endogenous low-density lipoprotein (LDL) receptor pro-
moter that we attempted to use as a positive control for
SREBP binding and whose regulation parallels FAS during
fasting and refeeding (14). As shown in the lower panel of Fig.
1C, we detected SREBP bound to the LDL receptor promoter
in the fed animals only. On the other hand, USF binding to the
LDL receptor promoter was detected both in the fasted and in
the fed states. The presence of an SRE in the LDL receptor
promoter has been studied previously (49). Although its func-
tion is not known, we found a canonical E-box located at
position 392/387 in the mouse LDL receptor promoter
where USF could bind. Overall, the in vivo pattern of binding
of USF and SREBP to the LDL receptor promoter was similar
to the one observed for the FAS promoter, suggesting a com-
mon mechanism of transcriptional activation of these two
genes by fasting and refeeding.
We also examined, using ChIP assays, the binding of other
transcription factors that may be involved in activation of the
FAS promoter during fasting and refeeding, either by directly
interacting with specific promoter sequences or through inter-
action with those transcription factors already characterized
above. It has been reported that SREBP interacts with the
coactivator CBP/p300 (8, 29) containing histone acetyltrans-
ferase activity. It has been proposed that SREBP may stimu-
late transcription by increasing histone acetylation through its
interaction with CBP/p300. Changes in the histone acetylation
status of the promoter can be detected by using antibodies
against acetylated H3 or H4 in the ChIP assay. In addition, the
transcription factors NF-Y, Sp1, and Sp3 have been described
as being involved in FAS regulation (36, 38), and it has been
hypothesized that NF-Y and Sp1 may facilitate SREBP recruit-
ment to its SREs in various promoters including FAS, HMG
CoA reductase, and LDL receptor promoters (4, 24). We
therefore examined whether the binding of NF-Y, Sp1, and
Sp3 to the FAS promoter was altered during nutritional regu-
lation, which could support their putative role in facilitating
SREBP binding. We carried out immunoprecipitation of chro-
matin preparations of liver samples obtained from 444 FAS-
CAT transgenic mice in fasted and refed states, using antibod-
ies against acetylated H3, acetylated H4, NF-Y, Sp1, and Sp3.
The presence of acetylated H3 and H4, as well as NF-Y bind-
ing, was observed in fasted animals in both the endogenous
and the transgene FAS promoter. We could not detect any
changes in binding during the different nutritional conditions
(Fig. 2A). In addition, we observed binding of both Sp1 and
Sp3 to the endogenous and the transgene FAS promoters (Fig.
2B), but we detected no significant changes in their binding,
and at most a slight decrease was observed when comparing
the refed with the fasted state. Thus, we conclude that the
acetylation status of H3 and H4 is not involved in FAS regu-
lation during fasting and refeeding and that NF-Y and Sp1/Sp3
may not function as facilitators of SREBP binding to the FAS
promoter in the refed state in vivo, as opposed to what has
been described in sterol depletion (4).
Although the central roles of USF and SREBP in transcrip-
tional regulation of FAS have been well established, there has
been controversy regarding which response elements these
transcription factors bind to confer transcriptional activation.
In fact, there are conflicting results regarding the DNA ele-
ments responsible for SREBP function in the FAS promoter.
So far, we and others employed transfection of the truncated
nuclear form of SREBP into cultured cells and electrophoretic
mobility shift assay with in vitro-transcribed and -translated
products (24–27). Additional difficulty in assigning the true site
of SREBP function could be ascribed to the dual DNA binding
specificity of SREBP (recognition of both SREs and E-boxes)
and the presence of several consensus binding sites in the
proximal region of the FAS promoter (19). In order to un-
equivocally determine the response element(s) in the FAS
promoter through which USF and SREBP function during
nutritional stimuli, we employed the ChIP assay on livers from
fasted and fasted-refed mice transgenic for our various 5-
deletion FAS promoter fragments linked to the CAT reporter
gene. The advantage of using various 5 deletions and muta-
tions of the FAS promoter is that the in vivo occupancy of each
of the specific response elements can be individually assessed.
That is, by comparing the binding of a given transcription
factor on a transgenic promoter construct containing the pu-
tative binding site with that for a second construct lacking the
putative element (through deletion or mutation), valid conclu-
sions can be drawn regarding the true response element for the
specific transcription factor. This cannot be achieved by exam-
ining the endogenous FAS promoter due to limitations of the
ChIP assay; the average length of the DNA fragments after
mechanical fragmentation by sonication of the cross-linked
chromatin is approximately 600 bp, and this makes it impossi-
ble to discriminate the contribution of each element for occu-
pancy by a given transcription factor.
FIG. 2. In vivo binding of NF-Y and Sp1/Sp3 to FAS promoter.
(A) PCR analysis of immunoprecipitates of liver samples from fasted
and refed 444 FAS-CAT transgenic animals when 5 l of anti-
acetylated-H3, 5 l of anti-acetylated-H4, and 30 g of anti-NF-Y
antibodies were used. ChIPs shown here are representative of at least
two independent experiments. (B) Same as panel A, but using 30 g of
anti-Sp1, 4 g of anti-Sp3, and 30 g of anti-NF-Y antibodies.












As depicted in Fig. 3, the 444 FAS promoter construct
contains the 65 region with an E-box that has been shown to
be responsible for insulin regulation in cultured cells. We
showed the E-box to be a USF binding site (48), while others
reported it to be a SREBP binding site (18). In addition, two
tandem SRE repeats that overlap with this E-box were de-
scribed for SREBP binding and function in activation of the
FAS promoter during sterol depletion (25). We first examined
transgenic mice containing the 131 FAS-CAT construct,
which does not show any CAT expression in either the fasted
or refed states (27). USF and/or SREBP binding to the 131
FAS promoter (which contains the 65 region) was examined
in fasted and refed mice liver by ChIP assays. As shown in Fig.
4A (upper panel), bound USF was detected in the 131 bp
FAS promoter transgene in liver samples from animals in both
the fasted and refed states (Fig. 4A, upper panel). As shown in
Fig. 1B, we could not detect USF binding to a downstream
region of the FAS gene which does not contain any USF
binding sites. We conclude that USF binds to the 65 E-box in
vivo, since it is the only E-box present in this 131 transgene
FAS promoter. Furthermore, SREBP binding could not be
detected within this 131 transgene promoter, even during
refeeding. As shown in Fig. 1B and C, during feeding we could
easily detect SREBP binding to the proximal promoter region
of the endogenous FAS gene. Similar to the results shown in
Fig. 1C, the control LDL receptor promoter showed SREBP
binding in the livers of the same refed animals (Fig. 4A, lower
panel).
We also performed ChIP on livers from mice transgenic for
both 131 FAS-CAT and PEPCK-SREBP-1a. In these mice, a
truncated active form of SREBP-1a is driven by the PEPCK
promoter, which is active during fasting and suppressed during
feeding, while the endogenous SREBP-1 levels would be very
low during fasting but induced during feeding (21, 40). There-
fore, the active form of SREBP in the double-transgenic mice
would be high whether the animals are fasted or fed (21).
When liver samples obtained from fasted and refed double-
transgenic animals were examined, binding of SREBP to the
transgene FAS promoter in vivo was not detected in either of
the nutritional conditions (Fig. 4B, upper panel). On the other
hand, SREBP occupancy of the LDL receptor promoter was
observed in both fasted and refed double-transgenic mice (Fig.
4B, lower panel), confirming that the PEPCK-SREBP-1a
transgene present in fasted animals could bind to the LDL
receptor promoter, while in the fed state, high endogenous
SREBP was bound to the LDL receptor promoter. The fact
that SREBP binding to the 131 FAS-CAT transgene was not
detected either upon stimulation of SREBP expression by
refeeding or by forced induction of the SREBP transgene in
fasting indicates that in living animals, SREBP cannot bind to
the E-box or the overlapping tandem SREs at the 65 region.
This supports previous reports where we showed with 3T3-L1
cells that USFs bind to the 65 E-box during insulin induction
of the FAS promoter. Furthermore, this also supports our
previous in vivo transgenic studies where we found that the
131 FAS promoter fragment could not mediate transcrip-
tional stimulation in vivo upon refeeding, probably because the
SREBP site is absent (21, 27).
Since the 131 FAS promoter fragment does not bind
SREBP, we decided to study the 278 bp FAS promoter
fragment. This promoter still contains the 150 SRE (but
lacks the 332 E-box) and will therefore provide unequivocal
evidence that SREBP, when it binds, interacts with the SRE
FIG. 3. Putative binding site for SREBP and USF in the FAS-
proximal promoter. The diagram represents the 444 bp fragment of
the FAS promoter.
FIG. 4. The 131 FAS promoter does not show binding of SREBP
in vivo during refeeding. (A) Livers from fasted and refed 131 FAS-
CAT transgenic mice were cross-linked, and the chromatin was iso-
lated, sonicated, and immunoprecipitated with antibodies against the
indicated proteins. The DNA was analyzed by PCR with primers for
the specified gene promoters. Binding to the LDL receptor (LDLR)
promoter is provided as a control. (B) Same as panel A, but the liver
samples were obtained from fasted and refed 131 FAS-CAT/SREBP
double-transgenic mice. The results shown here are representative of
at least three independent experiments.












and neither of the E-boxes. The first 278 bp of the FAS pro-
moter can respond to nutritional and hormonal stimuli in vivo,
although at a lower level than the larger 444 bp fragment
(27). We immunoprecipitated the cross-linked chromatin pre-
pared from the livers of 278 FAS-CAT transgenic mice that
were subjected to fasting or fasting-refeeding stimuli. Since we
did not find binding of SREBP to the 65 E-box or the over-
lapping SREs, as demonstrated with the 131 FAS promoter,
we predicted finding SREBP bound to the 150 SRE present
in this 278 FAS promoter fragment. We also predicted de-
tection of USF bound to the 278 FAS promoter, as in the
case of 131 FAS promoter, because of the presence of the
65 E-box. When we amplified the DNA fragments immuno-
precipitated by the USF1 and SREBP-1 antibodies by PCR, we
obtained results indistinguishable from those observed in the
444 FAS-CAT transgenic mice. As predicted, similar to the
131 FAS promoter, USF1 was bound to the transgene 278
FAS promoter regardless of nutritional status. SREBP-1, on
the other hand, could be detected only during the refed state
but not in the fasted state (Fig. 5A, upper panel). As before,
binding of these factors to the endogenous LDL receptor pro-
moter was used as a control (Fig. 5A, lower panel). The
present results clearly demonstrate inducible binding of
SREBP to the 150 SRE present in the region between 131
and 278 during fasting and refeeding. These results also
confirm our previous functional observations, which suggested
an involvement of SREBP function via the 278 FAS pro-
moter fragment during nutritional and hormonal regulation
(21). We next carried out the ChIP assay using livers from
278 FAS-CAT transgenic mice refed for various periods of
time. As shown in Fig. 5B, SREBP binding was detectable at
8 h of refeeding, reaching near maximal levels at 12 h. The time
course for binding of SREBP-1 to the transgene FAS promoter
correlated with the time course of FAS transcription during
refeeding that we and others have previously reported (7, 16,
31).
We also performed cross-linking and ChIP on livers from
fasted and refed mice transgenic for the 278 FAS-CAT and
PEPCK-SREBP-1a genes. We observed that USF was bound
to both endogenous FAS and the transgene FAS promoters
in double-transgenic mice in either the fasted or fed state.
SREBP was also bound to these promoters in both fasted and
fed conditions (Fig. 5C). As described above for the SREBP-
1a/131 FAS-CAT double-transgenic mice, the binding of
SREBP to this construct in the fasted state can be attributed to
the ectopically expressed, active form of SREBP-1a that is
present in these mice; binding of SREBP in the refed state is
due to induction of endogenous SREBP-1c. As for the control
promoter, USF and SREBP were bound to the LDL receptor
promoter in both fasted and fed conditions, in a manner sim-
ilar to that observed for the FAS promoter. The present ob-
servations on SREBP binding, therefore, support our previous
functional data obtained in vivo from these double-transgenic
mice, where we showed that SREBP is responsible for FAS
induction during fasting and refeeding (21). The results shown
herein clearly demonstrate that SREBP regulation of the FAS
promoter is due to direct binding of SREBP to the region of
the FAS promoter lying between 131 and 278.
To further address the function and occupancy of the 150
SRE and 65 E-box individually in FAS regulation, within the
FIG. 5. USF and SREBP binding to the FAS promoter during
nutritional regulation. (A) Cross-linked chromatin of livers from fasted
and refed 278 FAS-CAT transgenic mice was immunoprecipitated
with anti-USF and anti-SREBP antibodies, and the DNA pulled down
with the antibody-transcription factor complexes was analyzed for the
indicated gene promoters by PCR. Binding of the indicated proteins to
the LDL receptor (LDLR) promoter is shown as a control. (B) Livers
from 278 FAS-CAT mice refed for the specified times were dis-
sected, cross-linked, and immunoprecipitated with anti-USF and anti-
SREBP antibodies, and the DNA was analyzed by PCR with specific
primers for the transgene FAS promoter. (C) Same as panel A, but the
ChIP was performed on livers from fasted and refed 278 FAS-CAT/
SREBP double-transgenic animals. The results shown here are repre-
sentative of at least two independent experiments.












context of the 444 FAS-CAT promoter construct, we intro-
duced mutations into the 150 SRE or 65 E-box so that
SREBP and/or USF binding would be abolished. We chose the
444 construct since this fragment was able to support a full
response during fasting and refeeding (27). Three independent
founder lines were generated for each of the two constructs
containing mutations and subjected to fasting-refeeding exper-
iments. We then analyzed hepatic expression of the endoge-
nous FAS gene and CAT transgene driven by the mutated FAS
promoter by RNase protection assay (RPA) to determine the
functional requirements for each of these response elements,
as well as the binding of USF and SREBP by ChIP assay to
assess their contribution to activation of the FAS promoter.
We first analyzed mouse lines transgenic for the 444 FAS
CAT gene with a mutation at the 150 SRE: 444(150m)
FAS-CAT (Fig. 6A). Our immediate goal was to determine
whether the 150 SRE is required for transcriptional induc-
tion of FAS in response to fasting and refeeding. Therefore, we
analyzed the expression of the CAT transgene and endogenous
FAS gene in mRNA samples extracted from livers from fasted
or fasted and refed animals. -actin was used as a control for
RNA integrity and loading. The expression level for CAT was
compared to that of the transgenic mice harboring the wild-
type 444 FAS-CAT construct (Fig. 6B). As we have previ-
ously reported, these mice show increased levels for CAT
mRNA during refeeding, whereas expression levels were un-
detectable during fasting (27). On the other hand, expression
of the CAT transgene driven by the FAS promoter with a
mutation of the 150 SRE was absent or too low to be de-
tected even in the fed state in all three lines. In all transgenic
lines, expression of the endogenous FAS gene was induced by
fasting and refeeding, as expected. Hence, we conclude that
the 150 SRE is required for FAS regulation in fasting and
refeeding. Moreover, since essentially identical results were
obtained in all three lines, the lack of CAT expression is due to
the mutation itself and is not the result of transgene incorpo-
ration into silencing chromatin regions. ChIP analysis of cross-
linked livers from 444(150m) FAS-CAT transgenic mice
showed, contrary to what was observed in the livers of 444
FAS-CAT transgenic mice (Fig. 1C), that there is no binding of
SREBP to the transgene FAS promoter in chromatin extracted
from refed mice (Fig. 6C, upper panel). The control LDL
receptor promoter behaved as expected, showing SREBP
bound only in the refed state (Fig. 6C, lower panel). These
results clearly demonstrate the critical role for SREBP in the in
vivo nutritional regulation of FAS and firmly establish that its
role occurs through the 150 SRE.
We also analyzed the expression of CAT in mice transgenic
for the 444(150m) FAS-CAT along with PEPCK-SREBP-
1a (Fig. 6D). The mRNA levels for the 444 (150m) FAS-
CAT transgene were still undetectable in both fasted and refed
conditions, even though expression of the endogenous FAS
gene was high in both the fasted and refed states. This provides
unequivocal evidence that the 150 SRE is required for in-
duction of FAS transcription by SREBP per se. Furthermore,
when we performed ChIP on livers from fasted or refed
444(150m) FAS-CAT/SREBP double-transgenic mice, we
could not detect any SREBP bound to the transgene FAS
promoter, even though high levels of SREBP were present
both in the refed state and under conditions where SREBP was
artificially induced by the PEPCK promoter in fasting (Fig. 6E,
upper panel). On the other hand, the control LDL receptor
promoter showed SREBP binding in livers of both fasted and
refed double-transgenic mice (Fig. 6E, lower panel). We con-
clude that in the absence of the 150 SRE, binding of SREBP
to the FAS promoter does not occur in vivo in either the fasted
or refed state, even when a truncated active form of SREBP-1a
is overexpressed.
Next, we generated mice transgenic for the 444 FAS pro-
moter containing a mutation at the 65 E-box: 444(65m)
FAS-CAT (Fig. 7A). As expected, mRNA levels of the endog-
enous FAS gene were highly induced during refeeding, while
they remained low during fasting (Fig. 7B). Surprisingly, CAT
mRNA was not detectable in the livers of these transgenic mice
in either condition, even though the 150 SRE is intact in this
construct and should, at least in theory, be occupied by
SREBP. This indicates that the 65 E-box is also required,
although it is not sufficient for FAS regulation during fasting
and refeeding in vivo. We also examined the binding of both
USF and SREBP to the transgene FAS promoter by ChIP.
Even though the 65 E-box has been mutated, we could still
detect USF1 binding to the transgene promoter (Fig. 7C, up-
per panel). This was not surprising, since the 332 E-box is
still intact in this construct. In fact, this provides evidence for
the first time that the 332 E-box is a functional element to
which USF1 binds in vivo, in both fasted and refed condi-
tions. However, we could not detect SREBP bound to the
444(65m) FAS transgene promoter, even during refeeding
(Fig. 7C, upper panel), while SREBP was bound to the LDL
receptor promoter in the same samples prepared from livers of
refed transgenic mice (Fig. 7C, lower panel). The inability of
SREBP to bind the transgene FAS promoter was surprising,
since the 150 SRE is intact and therefore binding to the
promoter should not be impaired. Thus, the requirement of
the 65 E-box for the regulation of the FAS promoter by
SREBP in vivo at the functional level correlates with the im-
paired recruitment of SREBP to the promoter, and binding of
USF to this 65 element appears to be implicated in the
recruitment of SREBP to the 150 SRE.
DISCUSSION
Traditionally, in vitro DNA binding assays and cotransfec-
tion of reporter constructs along with expression vectors for
the transcription factors of interest are used to determine the
cis-acting elements and the role of a transcription factor in
promoter regulation. However, such experiments do not nec-
essarily reflect the conditions that the promoter sequences and
the transcription factors confront in vivo. For instance, the
chromatin structure of the endogenous gene and potential
competition with other binding proteins are not taken into
account in in vitro experiments. In contrast, the ChIP assay
allows the direct analysis of transcription factor site occupancy
in vivo. This technique has been applied recently to various
experimental systems to determine the physical association of
a specific DNA-binding factor with potential regulatory ele-
ments in living cells. Even so, cultured cells are not always
suitable due to their altered characteristics and the inability to
mimic complex regulatory networks; such is the case when
studying nutritional regulation, where many different pathways












FIG. 6. Requirement of the 150 SRE for nutritional regulation of FAS in vivo. (A) Diagram showing the mutation introduced at the 150
position within the context of the 444 bp FAS promoter used to generate the 444(150m) FAS-CAT transgenic mice. (B) RPA was performed
on mRNA extracted from the livers of fasted and refed 444(150m) FAS-CAT transgenic animals to determine the mRNA levels for
endogenous FAS and the reporter CAT genes. -actin mRNA levels are shown as controls. A, B, and C designate the three transgenic lines used
in the experiment. (C) ChIP was performed on cross-linked chromatin of livers from fasted and refed 444(150m) FAS-CAT transgenic mice
immunoprecipitated with antibodies against USF and SREBP. DNA was analyzed by PCR with the appropriate primers. LDL receptor (LDLR)
promoter is shown as a control. (D) Same as panel B, but the mRNA was prepared from the livers of 444(150m) FAS-CAT/SREBP
double-transgenic mice. Two transgenic lines were used in this experiment. (E) Same as panel C, but the cross-linked chromatin of livers from
444(150m) FAS-CAT/SREBP double-transgenic mice were used. The results shown are representative of a minimum of three independent













can converge to provide regulation of the target genes, such as
FAS.
Extensive studies on the transcriptional regulation of the
FAS gene have rendered considerable amounts of information
about the participating cis and trans factors acting during nu-
tritional and hormonal regulation (30, 31). The bHLH tran-
scription factors USF and SREBP have been shown to be key
players in such regulation through both in vivo and in vitro
studies (6, 21, 41, 44, 47, 48). Determining the cis elements
mediating USF and SREBP function, on the other hand, has
proven to be more elusive. Due to its low abundance, attempts
to detect endogenous SREBP in nuclear extracts by gel shift
analysis have been unsuccessful, and binding of SREBP to
specific sites has been addressed mainly by using in vitro-
transcribed and -translated SREBP. Moreover, the dual bind-
ing specificity of SREBP (to SRE and E-box) provided an
additional variable when trying to establish its response ele-
ment(s) within the FAS promoter (19). We previously showed
that the 65 E-box, where USF binds, is sufficient for insulin
regulation of the FAS promoter in 3T3-L1 adipocytes (47).
Others have shown that SREBP binding to this E-box is re-
sponsible for nutrient and insulin regulation (18). The Osborne
laboratory, on the other hand, reported that sterol regulation
of the FAS gene is mediated by binding of SREBP to the two
tandem SREs that overlap with the 65 E-box. Recently an-
other nuclear receptor, liver X receptor (LXR), has been im-
plicated in FAS regulation (1, 32, 39). LXR has been shown to
induce SREBP expression (22, 33, 51), thereby indirectly acti-
vating FAS transcription in fed mice. The Tontonoz laboratory
observed, by transfecting FAS promoter-reporter constructs
into cultured cells, that LXR also activates the FAS promoter
by binding to an LXRE located at position 660 (17). Our in
vivo studies, in contrast to the above-mentioned in vitro stud-
ies, showed that two regions of the FAS gene are required for
nutritional and insulin regulation: one at 278 to 131, albeit
at a low level, and the other at 444 to 278 for maximal
induction during fasting-refeeding and insulin injection. Fur-
thermore, our 444 FAS promoter construct lacking the pu-
tative LXRE at 660 could mediate a full response to fasting-
refeeding and insulin in vivo (27). Thus, attempts to determine
the function of SREBP by its transfection into cultured cells
may not yield physiologically relevant results, since established
cell lines hardly express the SREBP-1c isoform (43), the
SREBP isoform induced by fasting and refeeding (14). These
discrepancies between data obtained from in vitro studies and
our transgenic-mouse studies further demonstrate the signifi-
cance of in vivo approaches.
In this report, we have addressed the functional role and
occupancy by USF and/or SREBP of two response elements
within the FAS promoter, the 150 SRE and the 65 E-box,
by using previously generated mice transgenic for various 5-
deletion fragments of the FAS promoter driving the CAT gene
FIG. 7. The 65 E-box is necessary for FAS transcriptional regu-
lation in vivo. (A) The diagram shows the mutation introduced at the
65 E-box within the context of the 444 bp FAS promoter used to
generate the 444(65m) FAS-CAT transgenic mice. (B) RPA was
performed with mRNA extracted from the livers of fasted and refed
444(65m) FAS-CAT transgenic animals to determine the mRNA
levels for endogenous FAS and the reporter CAT. -Actin mRNA
levels are shown as controls. Three transgenic lines were used in this
experiment. (C) Immunoprecipitation was performed on cross-linked
chromatin of livers from fasted and refed 444(65m) FAS-CAT
transgenic mice with antibodies against the indicated proteins. DNA
was analyzed by PCR with the appropriate primers. The LDL receptor
(LDLR) promoter is shown as a control. The results shown are rep-
resentative of a minimum of three independent experiments for at
least two of the founder lines.












and newly generated mice transgenic for the FAS promoter
with specific mutations at these elements. The ChIP assay
allowed us to examine the occupancy of both the endogenous
FAS and transgene promoters by USF and SREBP in vivo
during fasting and refeeding. The analysis of transcription fac-
tor binding in living cells when the response elements are in
close proximity has previously been reported using cultured
cells stably transfected with different promoter-reporter con-
structs (5). However, to our knowledge, this is the first time
that this approach has been attempted with transgenic mice
harboring various promoter-reporter constructs in vivo. We
first characterized binding of SREBP to both the endogenous
and the 444 transgene FAS promoters during refeeding. The
importance of these results relies on the fact that binding of
SREBP to the transgene promoter mimics its binding to the
endogenous FAS promoter, which validates the use of the
transgene promoter as a model for studying binding of factors
to their response elements in an in vivo chromatin environ-
ment. As we previously reported, this construct supports full
transcriptional activation of the FAS gene by refeeding and
insulin (27). Our present observations show that SREBP bind-
ing to the FAS promoter is in fact altered during fasting and
refeeding in vivo, while USF binding is not. This is consistent
with the fact that while the level of USF does not change,
SREBP-1c, the SREBP isoform involved mainly in the regu-
lation of fatty acid synthesis, is dramatically induced by fasting
and refeeding in animals (14).
We have determined that SREBP binding to the FAS pro-
moter in vivo during refeeding occurs only through the 150
SRE. Contrary to the previous in vitro studies (18, 25), we
could not detect binding of SREBP to the 65 region in vivo,
either in the 131 bp fragment or when the 150 SRE was
mutated in the larger FAS promoter context. Furthermore,
even when we used transgenic mice overexpressing a truncated
active form of SREBP, binding of SREBP to the two transgene
FAS promoter constructs lacking the 150 SRE, either by
deletion or by site-specific mutation, could not be detected.
These observations are in agreement with the results obtained
from the functional assays performed during fasting and
refeeding in the present and the previously reported FAS-
promoter-CAT transgenic studies (21).
Our studies clearly demonstrate that USF binds in vivo to
both 65 and 332 E-boxes. Occupancy of the 332 E-box by
USF could be revealed by detection of USF bound to the 444
FAS promoter fragment even when the 65 E-box was mu-
tated. Since the 332 E-box is the sole E-box present in this
mutated construct, USF binding can only occur at the 332
E-box. Binding of USF to this E-box did not change during
fasting and refeeding, and USF binding to this element was not
sufficient to bring about transcriptional activation of the FAS
promoter. These observations support our previous hypothesis
that the 332 E-box may be critical in maintaining a high level
expression of FAS in the fed state but may not be directly
involved in the response to fasting and refeeding (27). When
we compared the promoter sequences between the rat and
human FAS genes, the 332 E-box was not present in the
human FAS promoter. However, we found an E-box approx-
imately 30 bp upstream of this, suggesting an important func-
tional role of this element in both species. Binding of USF to
the 65 E-box is established by the fact that binding of USF
was detected in the 131 bp fragment, where there are no
other E-boxes. As in the case of the 332 E-box, USF binding
to the 65 E-box was not altered during fasting and refeeding,
although posttranslational modification of USF upon refeed-
ing cannot be ruled out. Surprisingly, mutation of this element
within the context of a larger promoter fragment rendered the
transgenic promoter unable to respond to refeeding. This
clearly demonstrates a requirement for binding of USF to the
65 E-box in the nutritional regulation of the FAS gene in
vivo. Nevertheless, the 65 E-box alone is not sufficient for
FAS regulation in vivo, since such regulation was not observed
in the 131 bp promoter (27). We conclude that the 65
E-box is necessary but not sufficient for FAS regulation in vivo
and suggest that the loss of regulation observed when the 65
E-box is mutated could result from the inability of SREBP to
bind to the 150 SRE. Impairment of SREBP binding to the
150 SRE by mutation of the 65 E-box clearly shows the
requirement for USF binding to the 65 E-box in SREBP-
mediated FAS activation during fasting and refeeding. We do
not know the mechanism at this time, but we hypothesize that
USF binding to the 65 element would allow its interaction
with other transcription factors, basal transcription machinery,
or coactivators that may help SREBP to bind to its response
element. One way this may occur is through chromatin remod-
eling, making the 150 SRE accessible to SREBP. Others
have proposed the existence of a coactivator for SREBP/USF
that would be up-regulated by refeeding and insulin. Con-
versely, binding of USF to the 65 E-box may release a core-
pressor whose presence can prevent binding of SREBP to the
150 SRE. Regardless, this could explain the reported re-
quirement of USF for FAS activation in the refed state (6).
Although it has been reported that SREBP requires binding
of the coactivator CBP/p300 to regulate transcription (8), we
did not detect changes in the acetylation status of H3 and H4.
Although changes in histone acetylation have been described
for sterol-mediated regulation of LDL receptor and HMG-
CoA reductase gene transcription (4), these studies were con-
ducted in cultured cells where the major isoform expressed is
SREBP-1a (43). In our studies of fasted and refed mice in vivo,
the major isoform expressed would be SREBP-1c (14). In this
regard, it is interesting that Tjian and colleagues demonstrated
that CBP-associated HAT activity is not critical for the syner-
gistic activation by SREBP-1a/Sp1 on chromatin templates
(28). An alternative possibility is that the presence of USF
might be necessary and/or sufficient to keep the chromatin in
an “open” conformation and that this conformation is permis-
sive for SREBP-1c binding when it is induced by refeeding.
Nevertheless, recruitment of CBP could still occur, and CBP-
associated enzymatic activities other than acetylation, such as
kinase activity, might modify histones or other components of
the transcriptional apparatus (28). In fact, transcription factors
such as NF-Y and Sp1 have been reported to participate in the
nutritional regulation of the FAS gene (35–37), and these
transcription factors may interact with SREBP for transcrip-
tional regulation (2, 4, 28). Although we observed no signifi-
cant changes in NF-Y and Sp1/Sp3 binding, we cannot exclude
the possibility that these transcription factors might be re-
quired for recruitment of SREBP and/or be subjected to post-
translational modifications that would allow, in turn, an in-
crease in transcriptional activity. Further studies to determine












the existence and characterization of such coactivator(s) or
corepressor(s) will be needed.
In conclusion, we show here that USF binds in vivo to both
the 65 and 332 E-boxes, although its binding does not
change during fasting and refeeding. On the other hand, bind-
ing of SREBP to the 150 SRE in vivo perfectly correlates
with FAS activation during refeeding. We also show that both
the 150 SRE and the 65 E-box are absolutely required for
regulation of the FAS promoter by fasting and refeeding, al-
though none of these elements per se is sufficient for such
regulation in vivo.
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